Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

Corrigendum: Relacorilant, a Selective Glucocorticoid Receptor Modulator, Induces Clinical Improvements in Patients With Cushing Syndrome: Results From A Prospective, Open-Label Phase 2 Study.

Rosario Pivonello,Irina Bancos,Richard A Feelders,Atil Y Kargi,Janice M Kerr,Murray B Gordon,Cary N Mariash,Massimo Terzolo,Noel Ellison,Andreas G Moraitis

Frontiers in Endocrinology（2022）

Cited 0|Views11
No score
Abstract
[This corrects the article DOI: 10.3389/fendo.2021.662865.].
More
Translated text
Key words
clinical trial,cortisol,Cushing syndrome,glucocorticoid,hypercortisolism,hyperglycemia
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined